Sponsored Links

CVS Caremark Study Finds Value Based Insurance Designs Can Increase Adherence In Diabetes Patients PDF Print E-mail
Pharmacy - Pharmacy - Pharmacist
A study by CVS Caremark (NYSE: CVS), published this week in the American Journal of Pharmacy Benefits, finds that insurance benefit designs that reduce the cost of medications for plan participants result in patients being more likely to start and stay on their medication therapy...

Read more: Pharmacy / Pharmacist News From Medical News Today